OpenURL Connection Search

Select item for more details and to access through your institution.

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up.
Published in:
Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.777083
By:
- Sardu, Celestino;
- Massetti, Massimo;
- Testa, Nicola;
- Martino, Luigi Di;
- Castellano, Gaetano;
- Turriziani, Fabrizio;
- Sasso, Ferdinando Carlo;
- Torella, Michele;
- De Feo, Marisa;
- Santulli, Gaetano;
- Paolisso, Giuseppe;
- Marfella, Raffaele
Publication type:
Article
Does poor glycaemic control affect the immunogenicity of the COVID‐19 vaccination in patients with type 2 diabetes: The CAVEAT study.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 160, doi. 10.1111/dom.14547
By:
- Marfella, Raffaele;
- D'Onofrio, Nunzia;
- Sardu, Celestino;
- Scisciola, Lucia;
- Maggi, Paolo;
- Coppola, Nicola;
- Romano, Ciro;
- Messina, Vincenzo;
- Turriziani, Fabrizio;
- Siniscalchi, Mario;
- Maniscalco, Mauro;
- Boccalatte, Marco;
- Napolitano, Giovanni;
- Salemme, Luigi;
- Marfella, Ludovica Vittoria;
- Basile, Eugenio;
- Montemurro, Maria Vittoria;
- Papa, Carmela;
- Frascaria, Francesco;
- Papa, Antonio
Publication type:
Article
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
Published in:
Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01286-7
By:
- D'Onofrio, Nunzia;
- Scisciola, Lucia;
- Sardu, Celestino;
- Trotta, Maria Consiglia;
- De Feo, Marisa;
- Maiello, Ciro;
- Mascolo, Pasquale;
- De Micco, Francesco;
- Turriziani, Fabrizio;
- Municinò, Emilia;
- Monetti, Pasquale;
- Lombardi, Antonio;
- Napolitano, Maria Gaetana;
- Marino, Federica Zito;
- Ronchi, Andrea;
- Grimaldi, Vincenzo;
- Hermenean, Anca;
- Rizzo, Maria Rosaria;
- Barbieri, Michelangela;
- Franco, Renato
Publication type:
Article
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.
Published in:
2021
By:
- Marfella, Raffaele;
- Paolisso, Pasquale;
- Sardu, Celestino;
- Palomba, Luciana;
- D'Onofrio, Nunzia;
- Cesaro, Arturo;
- Barbieri, Michelangela;
- Rizzo, Maria Rosaria;
- Sasso, Ferdinando Carlo;
- Scisciola, Lucia;
- Turriziani, Fabrizio;
- Galdiero, Massimiliano;
- Pignataro, Danilo;
- Minicucci, Fabio;
- Trotta, Maria Consiglia;
- D'Amico, Michele;
- Mauro, Ciro;
- Calabrò, Paolo;
- Balestrieri, Maria Luisa;
- Signioriello, Giuseppe
Publication type:
journal article

Found: 4

Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up.

Does poor glycaemic control affect the immunogenicity of the COVID‐19 vaccination in patients with type 2 diabetes: The CAVEAT study.

Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.

SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.